By inhibiting HK2 and PKM2 in human ovarian cancer SKOV3 and 3AO cells, Ginsenoside 20(S)-Rg3 decreased tumor cell glycolysis (Li et al., 2015b). This evidence concerns the gene HK2 and neoplasm.